newsfilter
← Latest News
GlobeNewswire·

POINT Biopharma Announces Closing of Agreements with Lantheus Holdings

INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. ("POINT") (NASDAQ:PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today